Linear growth and bone maturation are unaffected by 1 year of therapy with inhaled flunisolide hydrofluoroalkane in prepubescent children with mild persistent asthma: A randomized, double-blind, placebo-controlled trial

In this study, flunisolide HFA did not suppress growth or bone maturation at the highest approved dose for children with persistent asthma.